Prof. Paul Dendale ,
Prof. Dominique Hansen,
Dr. Ines Frederix
Despite better coronary revascularization techniques and optimization of medication prescription in current cardiovascular medicine, multidisciplinary cardiac rehabilitation remains of paramount importance to reduce mortality after acute coronary events.Findings from a recent meta-analysis entitled ‘The prognostic effect of cardiac rehabilitation in the era of acute revascularization and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies – The Cardiac Rehabilitation Outcome Study (CROS)’- By Rauch B, Davos CH, Doherty P, et al. Eur J Prev Cardiol. 2016 Oct 24. pii: 2047487316671181
The prognostic effect of multidisciplinary cardiac rehabilitation within the contemporary era of improved acute coronary revascularization and optimized pharmacological treatment
The ESC guidelines recommend cardiac rehabilitation for ischemic heart disease patients (Class I for ST-elevation myocardial infarction patients, Class IIa for Non-ST-elevation myocardial infarction patients and Class I for stable coronary artery disease patients) [1-3]. Despite these strong recommendations, cardiac rehabilitation uptake rates remain poor. As evidenced by the EUROASPIRE IV survey, < 50% of eligible patients currently participate in cardiac rehabilitation programs .
The CROS trial: a new piece of evidence in support of cardiac rehabilitation
The Cardiac Rehabilitation Outcome Study (CROS) study group evaluated the prognostic effect of multi-component cardiac rehabilitation in patients with an acute coronary syndrome or previous coronary artery bypass graft and/or in mixed coronary artery disease patients . Twenty five studies were included in this systematic review and meta-analysis. Eventually, 219.702 ischemic heart disease patients from nine different countries worldwide were assessed. CROS was the first review of the prognostic effect of multi-component cardiac rehabilitation, in the current era of improved acute coronary revascularization and optimized pharmacological treatment (including statin therapy). The predominant finding of this review was that, despite these advances in cardiovascular medicine, multi-component cardiac rehabilitation was still associated with significantly reduced total mortality after a coronary artery bypass graft (HR 0.62) and an acute coronary syndrome (HR 0.37). The authors concluded that cardiac rehabilitation remains an effective therapeutic intervention to reduce the risk of premature death in ischemic heart disease patients. Innovations in cardiovascular medicine do not seem to replace the need for lifestyle changes after acute coronary syndromes/revascularization.
Despite the reported heterogeneity of the included studies in terms of study design, cardiac rehabilitation duration, intensity and/or volume and statistical methods applied, the CROS study adds very important and solid evidence in favor of cardiac rehabilitation in ischemic heart disease. It responds well to the EAPC, ACCA and CCNAP’s call for action to address the challenges in secondary prevention after an acute myocardial infarction, because this study is key in increasing awareness about the benefits of cardiac rehabilitation . Of note, the CROS study included studies assessing multi-component cardiac rehabilitation. This was defined as structured physical exercise training in combination with at least one other core component (information, motivational counseling, education, psychological, social and/or vocational support). It underscores that cardiac rehabilitation uses a comprehensive strategy including multiple core components; rather than solely focusing physical exercise training. The addition of nutritional counselling, risk factor control, psychosocial management, vocational support, therapy compliance and patient education is key to assure program success
Note: The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology
1. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.-By Steg G, James SK, Atar D, et al.- Eur Heart J 2012; 33: 2569–2619.2. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. By Roffi M, Patrono C, Collet JP, et al - Eur Heart J 2016; 37: 267–315.3. 2013 ESC guidelines on the management of stable coronary artery disease. By G, Sechtem U, Achenbach S, et al.- Eur Heart J 2013; 34: 2949–3003.4. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. By Kotseva K, De Bacquer D, De Backer G, et al.- Eur J Prev Cardiol 2016 Sep 16. pii: 2047487316667784.5. The prognostic effect of cardiac rehabilitation in the era of acute revascularization and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies – The Cardiac Rehabilitation Outcome Study. By Rauch B, Davos CH, Doherty P, et al.- Eur J Prev Cardiol 2016; 23: 1914-1939.6. Challenges in secondary prevention after acute myocardial infarction: A call for action. By Piepoli MF, Corrà U, Dendale P, et al.- Eur J Prev Cardiol 2016 Dec; 23(18):1994-2006
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved